XstalBio


XstalBio collaborates with international clients to advance biopharmaceuticals and vaccines by providing innovative technologies, expert consultancy, and scalable solutions to complex bioformulation challenges, accelerating biologics development and delivery.

Industries

biotechnology

Nr. of Employees

small (1-50)

XstalBio

XstalBio Limited, CIDS, Thomson Building, University Avenue, Glasgow G12 8QQ, U.K.


Products

Rapid protein reconstitution method

Method enabling rapid, foam-free reconstitution of high-concentration or viscous protein formulations into syringe-compatible solutions within minutes using standard containers and diluents.

Protein-coated microcrystal pulmonary delivery platform

Respirable dry powder platform based on protein-coated microcrystals providing controlled API payload, good powder handling and particle size control for pulmonary systemic or topical delivery.

Calcium phosphate-coated microcrystal sustained-release platform

Calcium phosphate-coated microcrystals for sustained local delivery of growth factors, hormones or antibodies, configurable for point-of-use preparation or supplied as stable dry powders; compatible with mixing into carriers used in orthobiologics.


Services

Contract analytical service providing solid-state CD analysis (rotating cell approach) for secondary and tertiary structure assessment of proteins in particles, lyophilised powders or scattering suspensions, with written interpretation and reporting.

Comprehensive analytical suite for particulate vaccines and colloidal biologics including physico-chemical testing, antigen–particle interaction analysis, particle characterisation, and ICH-aligned stability studies.

Development and manufacture support for respirable dry powder biologics, including particle engineering, performance testing (emitted dose, fine particle fraction) and scale-up to clinical batch production via third-party manufacturing.

Development, optimisation and licensing of particle-based delivery technologies for high-dose, sustained-release and adjuvanted vaccine applications; includes options for point-of-use preparation or supply as ready-made dry powders.

Expertise Areas

  • Biologic formulation and drug delivery
  • Pulmonary drug delivery development
  • Vaccine formulation and adjuvant optimisation
  • Particle engineering for multi-active delivery
  • Show More (4)

Key Technologies

  • Solid-state circular dichroism (near/far-UV)
  • Solid-state fluorescence
  • Differential scanning calorimetry
  • Mass spectrometry (tryptic fingerprinting)
  • Show More (9)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.